Clinical Trial Update: Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 study evaluating cyproterone acetate for hot flashes after surgical or chemical castration in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cyproterone acetate (cyproterone acetate)

Snippet

Sponsor: Barr Laboratories | Conditions: Hot Flashes, Prostate Cancer | Phase 3 | Status: COMPLETED